Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
India | 26 | 2024 | 2336 | 1.640 |
Why?
|
Infant Mortality | 5 | 2024 | 756 | 1.610 |
Why?
|
Postnatal Care | 3 | 2024 | 260 | 1.490 |
Why?
|
Prenatal Care | 5 | 2024 | 1129 | 1.370 |
Why?
|
Tropomyosin | 5 | 2009 | 104 | 1.370 |
Why?
|
Nanotubes | 2 | 2023 | 77 | 1.150 |
Why?
|
Sterilization, Reproductive | 2 | 2018 | 24 | 1.060 |
Why?
|
Marriage | 4 | 2018 | 350 | 0.880 |
Why?
|
Actins | 5 | 2009 | 2049 | 0.820 |
Why?
|
Sex Ratio | 1 | 2021 | 107 | 0.730 |
Why?
|
Molecular Dynamics Simulation | 4 | 2015 | 435 | 0.730 |
Why?
|
Domestic Violence | 1 | 2022 | 181 | 0.710 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2020 | 20 | 0.700 |
Why?
|
Spouses | 1 | 2022 | 279 | 0.670 |
Why?
|
Family Characteristics | 3 | 2021 | 1001 | 0.660 |
Why?
|
Family Planning Services | 2 | 2012 | 265 | 0.650 |
Why?
|
Gap Junctions | 1 | 2020 | 230 | 0.620 |
Why?
|
Stem Cell Niche | 1 | 2020 | 346 | 0.540 |
Why?
|
Adolescent Development | 1 | 2019 | 282 | 0.510 |
Why?
|
Miconazole | 1 | 2014 | 9 | 0.480 |
Why?
|
Vinyl Compounds | 1 | 2014 | 22 | 0.480 |
Why?
|
Socioeconomic Factors | 6 | 2016 | 7805 | 0.450 |
Why?
|
Nanotechnology | 2 | 2010 | 709 | 0.450 |
Why?
|
Pregnancy, Unwanted | 1 | 2013 | 24 | 0.440 |
Why?
|
Population Control | 1 | 2012 | 22 | 0.430 |
Why?
|
Nucleic Acid Conformation | 4 | 2021 | 899 | 0.420 |
Why?
|
Body Height | 1 | 2019 | 1570 | 0.410 |
Why?
|
Peptides | 2 | 2023 | 4354 | 0.410 |
Why?
|
Malnutrition | 1 | 2019 | 640 | 0.400 |
Why?
|
Pyrrolidines | 1 | 2014 | 340 | 0.400 |
Why?
|
Pregnancy, Unplanned | 1 | 2013 | 88 | 0.400 |
Why?
|
Protein Denaturation | 2 | 2009 | 242 | 0.400 |
Why?
|
Growth Disorders | 1 | 2017 | 653 | 0.400 |
Why?
|
Leishmaniasis, Visceral | 2 | 2024 | 99 | 0.390 |
Why?
|
Nutritional Status | 2 | 2019 | 1607 | 0.380 |
Why?
|
Rural Population | 4 | 2023 | 2268 | 0.370 |
Why?
|
Maternal Behavior | 1 | 2012 | 306 | 0.350 |
Why?
|
Health Surveys | 5 | 2022 | 4063 | 0.350 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2829 | 0.350 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2010 | 89 | 0.340 |
Why?
|
Polymers | 3 | 2024 | 1621 | 0.340 |
Why?
|
Trabeculectomy | 2 | 2021 | 174 | 0.330 |
Why?
|
Muscle Neoplasms | 1 | 2010 | 133 | 0.330 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 778 | 0.310 |
Why?
|
Birth Weight | 1 | 2017 | 2097 | 0.310 |
Why?
|
Weight Gain | 1 | 2019 | 2347 | 0.310 |
Why?
|
Boron | 1 | 2008 | 37 | 0.310 |
Why?
|
Models, Chemical | 2 | 2021 | 614 | 0.300 |
Why?
|
Maternal Health Services | 1 | 2013 | 455 | 0.290 |
Why?
|
Parturition | 1 | 2011 | 446 | 0.290 |
Why?
|
Child Health Services | 1 | 2013 | 644 | 0.290 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3390 | 0.290 |
Why?
|
Metals | 1 | 2011 | 736 | 0.280 |
Why?
|
Emotions | 1 | 2018 | 2734 | 0.270 |
Why?
|
DNA | 3 | 2024 | 7233 | 0.260 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1130 | 0.260 |
Why?
|
Models, Molecular | 4 | 2009 | 5434 | 0.250 |
Why?
|
Infant, Newborn | 8 | 2024 | 26179 | 0.250 |
Why?
|
Catalysis | 2 | 2023 | 775 | 0.240 |
Why?
|
Public Health | 2 | 2021 | 2653 | 0.240 |
Why?
|
beta-Cyclodextrins | 1 | 2024 | 68 | 0.240 |
Why?
|
Counseling | 1 | 2012 | 1548 | 0.240 |
Why?
|
Logistic Models | 6 | 2017 | 13312 | 0.230 |
Why?
|
Emulsions | 1 | 2024 | 152 | 0.230 |
Why?
|
Plant Leaves | 1 | 2024 | 151 | 0.230 |
Why?
|
Protein Folding | 2 | 2007 | 867 | 0.230 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1096 | 0.220 |
Why?
|
Antibodies, Protozoan | 1 | 2024 | 251 | 0.210 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2023 | 82 | 0.210 |
Why?
|
Alginates | 1 | 2024 | 248 | 0.210 |
Why?
|
Nanostructures | 1 | 2008 | 547 | 0.210 |
Why?
|
Pregnancy | 9 | 2024 | 29746 | 0.210 |
Why?
|
Circular Dichroism | 3 | 2009 | 348 | 0.210 |
Why?
|
Stereoisomerism | 1 | 2023 | 617 | 0.210 |
Why?
|
Solubility | 1 | 2024 | 1088 | 0.210 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2210 | 0.210 |
Why?
|
Antiphospholipid Syndrome | 1 | 2023 | 165 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 3985 | 0.200 |
Why?
|
RNA | 1 | 2011 | 2723 | 0.190 |
Why?
|
Phlebotomus | 1 | 2021 | 12 | 0.190 |
Why?
|
Psychodidae | 1 | 2021 | 26 | 0.190 |
Why?
|
Plant Extracts | 1 | 2024 | 496 | 0.180 |
Why?
|
Ethiopia | 2 | 2021 | 462 | 0.180 |
Why?
|
Leishmania donovani | 1 | 2021 | 68 | 0.180 |
Why?
|
Humans | 48 | 2024 | 760613 | 0.170 |
Why?
|
Female | 30 | 2024 | 391246 | 0.170 |
Why?
|
Vaccines, Acellular | 1 | 2019 | 11 | 0.170 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2021 | 136 | 0.170 |
Why?
|
Young Adult | 10 | 2024 | 58748 | 0.170 |
Why?
|
Parathyroid Hormone | 2 | 2016 | 1797 | 0.170 |
Why?
|
Phacoemulsification | 1 | 2021 | 149 | 0.160 |
Why?
|
Kidney Calculi | 1 | 2023 | 468 | 0.160 |
Why?
|
Bordetella pertussis | 1 | 2019 | 45 | 0.160 |
Why?
|
Metal Nanoparticles | 2 | 2015 | 399 | 0.160 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2021 | 191 | 0.160 |
Why?
|
Infant | 7 | 2024 | 36053 | 0.160 |
Why?
|
DNA, Single-Stranded | 1 | 2021 | 360 | 0.160 |
Why?
|
Thermodynamics | 3 | 2024 | 599 | 0.160 |
Why?
|
Temperature | 3 | 2014 | 2221 | 0.160 |
Why?
|
Drug Carriers | 2 | 2024 | 709 | 0.160 |
Why?
|
Child Welfare | 2 | 2013 | 516 | 0.160 |
Why?
|
Nanoparticles | 3 | 2018 | 1943 | 0.160 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 293 | 0.160 |
Why?
|
Technology, Pharmaceutical | 1 | 2018 | 84 | 0.160 |
Why?
|
Adolescent | 10 | 2024 | 87809 | 0.150 |
Why?
|
Vietnam | 1 | 2019 | 411 | 0.150 |
Why?
|
Base Sequence | 4 | 2024 | 12444 | 0.150 |
Why?
|
Depression | 3 | 2023 | 8045 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2020 | 3800 | 0.150 |
Why?
|
Amyloid | 1 | 2022 | 842 | 0.140 |
Why?
|
Calorimetry, Differential Scanning | 2 | 2009 | 98 | 0.140 |
Why?
|
Directly Observed Therapy | 1 | 2017 | 139 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3802 | 0.140 |
Why?
|
Mouth Neoplasms | 1 | 2022 | 593 | 0.140 |
Why?
|
Head and Neck Neoplasms | 2 | 2022 | 2882 | 0.140 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2016 | 161 | 0.130 |
Why?
|
Fertility | 1 | 2021 | 773 | 0.130 |
Why?
|
Nanomedicine | 1 | 2018 | 288 | 0.130 |
Why?
|
Peru | 1 | 2019 | 869 | 0.130 |
Why?
|
Streptococcal Infections | 1 | 2020 | 617 | 0.130 |
Why?
|
Health Transition | 1 | 2015 | 35 | 0.130 |
Why?
|
Surface Properties | 1 | 2018 | 1161 | 0.130 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 150 | 0.130 |
Why?
|
Menopause, Premature | 1 | 2016 | 125 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4924 | 0.120 |
Why?
|
Ovariectomy | 1 | 2017 | 611 | 0.120 |
Why?
|
Women's Health | 2 | 2016 | 2056 | 0.120 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2138 | 0.120 |
Why?
|
Glaucoma, Open-Angle | 1 | 2021 | 734 | 0.120 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2016 | 342 | 0.120 |
Why?
|
Alendronate | 1 | 2015 | 174 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 220359 | 0.120 |
Why?
|
Protein Binding | 4 | 2009 | 9335 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 3765 | 0.120 |
Why?
|
Cations | 2 | 2012 | 239 | 0.120 |
Why?
|
Laser Therapy | 1 | 2021 | 1089 | 0.120 |
Why?
|
Adult | 15 | 2024 | 220007 | 0.110 |
Why?
|
Gold | 3 | 2015 | 484 | 0.110 |
Why?
|
Tablets | 1 | 2014 | 149 | 0.110 |
Why?
|
Iron Compounds | 1 | 2013 | 28 | 0.110 |
Why?
|
Drugs, Investigational | 1 | 2015 | 214 | 0.110 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.110 |
Why?
|
Male | 19 | 2024 | 359718 | 0.110 |
Why?
|
Health Personnel | 3 | 2023 | 3310 | 0.110 |
Why?
|
Humidity | 1 | 2014 | 205 | 0.110 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 276 | 0.110 |
Why?
|
Tetanus Toxoid | 1 | 2013 | 193 | 0.110 |
Why?
|
Phagocytosis | 1 | 2019 | 1535 | 0.110 |
Why?
|
Nucleic Acids | 1 | 2015 | 188 | 0.110 |
Why?
|
Bone Remodeling | 1 | 2016 | 580 | 0.100 |
Why?
|
Perinatal Mortality | 1 | 2013 | 101 | 0.100 |
Why?
|
Isoxazoles | 1 | 2014 | 230 | 0.100 |
Why?
|
Sarcopenia | 1 | 2017 | 372 | 0.100 |
Why?
|
Child, Preschool | 6 | 2024 | 42056 | 0.100 |
Why?
|
Maternal Welfare | 1 | 2012 | 112 | 0.100 |
Why?
|
Hospitals, Private | 1 | 2012 | 63 | 0.100 |
Why?
|
Birth Order | 1 | 2012 | 95 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2023 | 1245 | 0.100 |
Why?
|
Pregnancy, High-Risk | 1 | 2012 | 119 | 0.100 |
Why?
|
Home Childbirth | 1 | 2012 | 55 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2015 | 409 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2024 | 22052 | 0.100 |
Why?
|
Amino Acid Sequence | 3 | 2009 | 13451 | 0.100 |
Why?
|
Adiponectin | 1 | 2017 | 1114 | 0.100 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13262 | 0.090 |
Why?
|
Base Pairing | 1 | 2011 | 140 | 0.090 |
Why?
|
Cultural Characteristics | 1 | 2012 | 253 | 0.090 |
Why?
|
Poly T | 1 | 2010 | 6 | 0.090 |
Why?
|
Quartz Crystal Microbalance Techniques | 1 | 2010 | 9 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2160 | 0.090 |
Why?
|
Refractometry | 1 | 2011 | 57 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2023 | 5132 | 0.090 |
Why?
|
Surgical Flaps | 1 | 2020 | 1669 | 0.090 |
Why?
|
Pressure | 1 | 2014 | 1156 | 0.090 |
Why?
|
Hospitals, Public | 1 | 2012 | 201 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17624 | 0.090 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 992 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3164 | 0.090 |
Why?
|
Rats | 4 | 2009 | 23709 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2063 | 0.090 |
Why?
|
Solvents | 1 | 2011 | 292 | 0.090 |
Why?
|
Software | 1 | 2024 | 4419 | 0.090 |
Why?
|
Odds Ratio | 2 | 2013 | 9716 | 0.090 |
Why?
|
Thrombosis | 1 | 2023 | 3051 | 0.080 |
Why?
|
Geography | 1 | 2011 | 661 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 854 | 0.080 |
Why?
|
Mitochondria | 2 | 2020 | 3601 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1634 | 0.080 |
Why?
|
Maternal Age | 1 | 2012 | 807 | 0.080 |
Why?
|
Nucleic Acid Hybridization | 1 | 2010 | 1304 | 0.080 |
Why?
|
Animals | 12 | 2021 | 167960 | 0.080 |
Why?
|
Body Temperature | 1 | 2012 | 777 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 685 | 0.080 |
Why?
|
Estrogens | 1 | 2015 | 1520 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8623 | 0.080 |
Why?
|
Prospective Studies | 7 | 2023 | 54306 | 0.080 |
Why?
|
Life Expectancy | 1 | 2015 | 1247 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1640 | 0.080 |
Why?
|
Premature Birth | 1 | 2020 | 1770 | 0.080 |
Why?
|
Body Composition | 1 | 2017 | 2419 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5251 | 0.070 |
Why?
|
Actomyosin | 1 | 2007 | 109 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1486 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2015 | 878 | 0.070 |
Why?
|
Molecular Conformation | 1 | 2008 | 548 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2893 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1309 | 0.070 |
Why?
|
Parenting | 1 | 2012 | 695 | 0.070 |
Why?
|
Lasers | 1 | 2011 | 952 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4024 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2022 | 11152 | 0.070 |
Why?
|
Macromolecular Substances | 1 | 2008 | 1433 | 0.060 |
Why?
|
Lymph Nodes | 2 | 2022 | 3486 | 0.060 |
Why?
|
Homeostasis | 1 | 2016 | 3306 | 0.060 |
Why?
|
Histones | 1 | 2015 | 2582 | 0.060 |
Why?
|
Intraocular Pressure | 2 | 2021 | 1288 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2020 | 11481 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.060 |
Why?
|
DNA Primers | 1 | 2009 | 2818 | 0.060 |
Why?
|
Delivery, Obstetric | 1 | 2012 | 932 | 0.060 |
Why?
|
Agglutination Tests | 1 | 2024 | 41 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11713 | 0.060 |
Why?
|
Tuberculosis | 1 | 2017 | 2001 | 0.060 |
Why?
|
Environmental Monitoring | 1 | 2011 | 1441 | 0.060 |
Why?
|
Methacrylates | 1 | 2024 | 109 | 0.060 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2023 | 62 | 0.060 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2023 | 34 | 0.060 |
Why?
|
Prevalence | 2 | 2020 | 15686 | 0.060 |
Why?
|
Polyvinyls | 1 | 2024 | 154 | 0.060 |
Why?
|
Particle Size | 1 | 2008 | 1644 | 0.060 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2023 | 71 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 13982 | 0.050 |
Why?
|
Models, Biological | 1 | 2020 | 9468 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3865 | 0.050 |
Why?
|
Drug Compounding | 1 | 2024 | 246 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21029 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 394 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2943 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1229 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2477 | 0.050 |
Why?
|
Suction | 1 | 2023 | 263 | 0.050 |
Why?
|
Computer Simulation | 2 | 2008 | 6218 | 0.050 |
Why?
|
Coenzymes | 1 | 2022 | 102 | 0.050 |
Why?
|
Antigens, Protozoan | 1 | 2024 | 316 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2315 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.050 |
Why?
|
Child | 5 | 2024 | 79799 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 3051 | 0.050 |
Why?
|
Fungi | 1 | 2024 | 339 | 0.050 |
Why?
|
Postmenopause | 1 | 2011 | 2509 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2061 | 0.050 |
Why?
|
Mutation | 4 | 2020 | 29957 | 0.050 |
Why?
|
Xenodiagnosis | 1 | 2021 | 1 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 1913 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2003 | 929 | 0.050 |
Why?
|
Alanine | 1 | 2003 | 606 | 0.050 |
Why?
|
Osteoblasts | 2 | 2017 | 1142 | 0.050 |
Why?
|
Trabecular Meshwork | 1 | 2021 | 100 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5251 | 0.050 |
Why?
|
Scattering, Small Angle | 1 | 2021 | 64 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14494 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2015 | 4412 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3392 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9288 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
Systems Analysis | 1 | 2021 | 169 | 0.040 |
Why?
|
X-Ray Diffraction | 1 | 2021 | 421 | 0.040 |
Why?
|
Asthenia | 1 | 2019 | 16 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Time Factors | 2 | 2012 | 40139 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23374 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14661 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12159 | 0.040 |
Why?
|
Pertussis Vaccine | 1 | 2019 | 39 | 0.040 |
Why?
|
Platinum Compounds | 1 | 2019 | 95 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6216 | 0.040 |
Why?
|
Particulate Matter | 1 | 2011 | 2559 | 0.040 |
Why?
|
Complement Factor H | 1 | 2019 | 109 | 0.040 |
Why?
|
Age Factors | 2 | 2016 | 18413 | 0.040 |
Why?
|
Patient Simulation | 1 | 2021 | 297 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2024 | 1189 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 2020 | 337 | 0.040 |
Why?
|
Occupations | 1 | 2021 | 515 | 0.040 |
Why?
|
Siblings | 1 | 2023 | 824 | 0.040 |
Why?
|
Stroke | 1 | 2021 | 9952 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 176 | 0.040 |
Why?
|
Whooping Cough | 1 | 2019 | 85 | 0.040 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2021 | 419 | 0.040 |
Why?
|
Cohort Studies | 2 | 2021 | 41337 | 0.040 |
Why?
|
Water | 1 | 2024 | 1407 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2023 | 64981 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2024 | 1949 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 511 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 80345 | 0.040 |
Why?
|
Policy | 1 | 2022 | 511 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2019 | 818 | 0.040 |
Why?
|
Vaccination | 2 | 2021 | 3359 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3925 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8556 | 0.040 |
Why?
|
Adenylate Kinase | 1 | 2017 | 102 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2024 | 981 | 0.040 |
Why?
|
Lumbar Vertebrae | 2 | 2017 | 1868 | 0.040 |
Why?
|
Cell Respiration | 1 | 2017 | 202 | 0.030 |
Why?
|
Genome, Viral | 1 | 2020 | 658 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13627 | 0.030 |
Why?
|
Peritonitis | 1 | 2019 | 369 | 0.030 |
Why?
|
Prognosis | 2 | 2022 | 29661 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2019 | 628 | 0.030 |
Why?
|
Diaphyses | 1 | 2015 | 65 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 495 | 0.030 |
Why?
|
Sanitation | 1 | 2015 | 85 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2015 | 170 | 0.030 |
Why?
|
Vagina | 1 | 2020 | 837 | 0.030 |
Why?
|
Autoantigens | 1 | 2019 | 877 | 0.030 |
Why?
|
Crystallization | 1 | 2015 | 533 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5725 | 0.030 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2014 | 28 | 0.030 |
Why?
|
Biofilms | 1 | 2019 | 621 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1174 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2764 | 0.030 |
Why?
|
Primary Health Care | 2 | 2021 | 4647 | 0.030 |
Why?
|
Anabolic Agents | 1 | 2016 | 253 | 0.030 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
Bone Resorption | 1 | 2017 | 720 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2567 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2023 | 6015 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 1039 | 0.030 |
Why?
|
Antigens | 1 | 2019 | 1447 | 0.030 |
Why?
|
Parity | 1 | 2016 | 925 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 465 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2775 | 0.030 |
Why?
|
Calcineurin | 1 | 2014 | 229 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2024 | 4716 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 389 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2019 | 1468 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 910 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2298 | 0.030 |
Why?
|
Risk Factors | 2 | 2017 | 74333 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 201 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 2012 | 110 | 0.030 |
Why?
|
Luciferases | 1 | 2014 | 716 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 841 | 0.030 |
Why?
|
Computational Biology | 1 | 2024 | 3505 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2014 | 381 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2108 | 0.020 |
Why?
|
Internet | 1 | 2024 | 3078 | 0.020 |
Why?
|
Osteoclasts | 1 | 2015 | 712 | 0.020 |
Why?
|
Visual Acuity | 1 | 2021 | 2643 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10789 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2609 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1271 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2119 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3157 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2448 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4286 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1511 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1529 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2014 | 1456 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 732 | 0.020 |
Why?
|
Femur | 1 | 2015 | 1302 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4773 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3213 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1723 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4122 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2884 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3928 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25941 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1754 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1846 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20509 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4542 | 0.020 |
Why?
|
Mice | 3 | 2019 | 81209 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10185 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4219 | 0.020 |
Why?
|
Aged | 3 | 2019 | 169143 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4167 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8158 | 0.020 |
Why?
|
Osteoporosis | 1 | 2015 | 1601 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2015 | 1809 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4263 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5797 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2622 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10343 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8022 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3520 | 0.010 |
Why?
|
Bone Density | 1 | 2015 | 3534 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9278 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14374 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18137 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24102 | 0.010 |
Why?
|